Immunohistochemical analysis of Ki-67, PCNA and S6K1/2 expression in human breast cancer

Experimental Oncology

Volumn 27, Issue 2, 2005, Pages 141-144

  Lyzogubov, Valeriy ^a,b   Khozhaenko, Yulia ^b   Usenko, Vasilij ^b   Antonjuk, Stepan ^c   Ovcharenko, Galina ^d   Tikhonkova, Iryna ^d   Filonenko, Valeriy ^d  

^a R E KAVETSKY INSTITUTE OF EXPERIMENTAL PATHOLOGY   (Ukraine)

^b Morphological Laboratory BIONTEC   (Ukraine)

^c Municipal Oncocenter   (Ukraine)

^d INSTITUTE OF MOLECULAR BIOLOGY AND GENETICS   (Ukraine)

Author keywords

Breast adenocarcinoma; Immunohistochemistry; Ki 67; PCNA; S6K1; S6K2

Indexed keywords

CYCLINE; KI 67 ANTIGEN; MONOCLONAL ANTIBODY; PARAFFIN; POLYCLONAL ANTIBODY; S6 KINASE; S6 KINASE 1; S6 KINASE 2; UNCLASSIFIED DRUG;

ARTICLE; BREAST ADENOCARCINOMA; CANCER CELL; CANCER GROWTH; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALIGNANT TRANSFORMATION; PROTEIN PHOSPHORYLATION;

BREAST; BREAST NEOPLASMS; CELL NUCLEUS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; KI-67 ANTIGEN; NEOPLASM STAGING; PARAFFIN EMBEDDING; PROGNOSIS; PROLIFERATING CELL NUCLEAR ANTIGEN; RIBOSOMAL PROTEIN S6 KINASES; TUMOR MARKERS, BIOLOGICAL;

EID: 22644436370     PISSN: 18129269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Richardson CJ, Schalm SS, Blenis J. PI3-kinase and TOR: PICTORing cell growth. Sem Cell Devel Biol 2004; 15: 147-59.
2. Pende M, Kozma SC, Jaquet M, Oorschot V, Burcelin R, Le Marchand-Brustel Y, Klumperman J, Thorens B, Thomas G. Hypoinsulinaemia, glucose intolerance and diminished beta-cell size in S6K1-deficient mice. Nature 2000; 408: 994-7.
3. Shima H, Pende M, Chen Y, Fumagalli S, Thomas G, Kozma SC. Disruption of the p70(s6k)/p85(s6k) gene reveals a small mouse phenotype and a new functional S6 kinase. EMBO J 1998; 17: 6649-59.
4. Richardson CJ, Broenstrup M, Fingar DC, Julich K, Ballif BA, Gygi S, Blenis J. SKAR is a specific target of S6 kinase 1 in cell growth control. Curr Biol 2004; 14: 1540-9.
5. Raght B, Peiretti F, Gingras AC, Livingstone M, Shahbazian D, Mayeur GL, Polakievicz RD, Sonenberg N, Hershey JWB. Phosphorylation of eukaryotic translation initiation factor 4B Ser422 is modulated by S6 kinase. EMBO J 2004; 23: 1761-9.
6. Harada H, Andersen JS, Mann M, Terada N, Korsmeyer SJ. p70S6 kinase signals cell survival as well as growth, inactivating the pro-apoptotic molecule BAD. Proc Natl Acad Sci USA 2001; 98: 9666-70.
7. Harrington LS, Findlay GM, Lamb RF. Restraining PI3K: mTOR signalling goes back to the membrane. Trends Biochem Sci 2005; 30: 35-42.
8. Kim JE, Chen J. Cytoplasmic-nuclear shuttling of EKBP12-rapamycine- assosiated protein is involved in rapamycine-sensitive signaling and translation initiation. Proc Natl Acad Sci USA 2000; 97: 14340-5.
9. Koh H, Jee K, Lee B, Kim J, Kim D, Yun YH, Kim JW, Choi HS, Chung J. Cloning and characterization of a nuclear S6 kinase, S6 kinase-related kinase (SRK); a novel nuclear target of Akt. Oncogene 1999; 18: 5115-9.
10. Valovka T, Verdier F, Cramer R, Zhyvoloup A, Fenton T, Rebholz H, Wang M-L, Gzhegotsky M, Lutsyk A, Matsuka G, Filonenko V, Wang L, Proud CG, Parker PJ, Gout IT. Protein kinase C phosphorylates ribosomal protein S6 kinase βII and regulates its subcellular localization. Mol Cell Biol 2003; 23: 852-63.
11. Van der Hage JA, van den Broek LJCM, Legrand C, Clahsen PC, Bosch CJA, Robanus-Maandag EC, van de CJH, van de Vijver MJ. Overexpression of p70 S6 kinase protein is assosiated with increased risk of locoregional recurrence in node-negative premenopausal early breast cancer patients. Br J Cancer 2004; 90: 1543-50.
12. Filonenko VV Tytarenko R, Azatjan SK, Savinska LO, Gaydar YA, Gout IT, Usenko VS, Lyzogubov VV. Immunohistochemical analysis of S6K1 and S6K2 subcellular localization in human breast tumors. Exp Oncol 2004; 26: 294-9.
13. Miyakawa M, Tsushima T, Murakami H, Wakai K, Isozaki O, Takano K. Increased expression of phosphorilated p70S6 kinase and Akt in papillary thyroid tissues. Endocr J 2003; 50: 77-83.
14. Lytvin DI, Dudchenko TM, Lysogubov VV, Usenko VS, Nespryadko SV, Vinnitskaya AB, Vorobyova LI, Pal'chevskiy SS, Filonenko VV, Pogrebnoy PV. Expression of α- and β-isoforms of p70 S6 kinase in human endometrial tumors. Exp Oncol 2003; 25: 274-8.
15. Wong AS, Kim SO, Leung PC, Auersperg N, Pelech SL. Profiling of protein kinases in the neoplastic transformation of human ovarian surface epithelium. Gynecol Oncol 2001; 82: 305-11.
16. Harrington LS, Findlay GM, Lamb RF. Restraining PI3K: mTOR signalling goes back to the membrane. Trends Biochem Sci 2005; 30: 35-42.
17. Savinska LO, Lyzogubov VV, Usenko VS, Ovcharenko GV, Gorbenko ON, Rodnin MV, Vudmaska MI, Pogribniy PV, Kyyamova RG, Panasyuk GG, Nemazanyy IO, Malets MS, Palchevskyy SS, Gout IT, Filonenko VV. Immunohistochemical analysis of S6K1 and S6K2 expression in human breast tumors. Exp Oncol 2004; 26: 24-30.
18. Tachibana KE, Gonzalez MA, Coleman N. Cell-cycle-dependent regulation of DNA replication and its relevance to cancer pathology. J Pathol 2005; 205: 123-9.
19. Reinhard C, Fernandez A, Lamb NJ, Thomas G. Nuclear localization of p85s6k: functional requirement for entry into S phase. EMBO J 1994; 13: 1557-65.
20. Brown EJ, Schreiber SL. A signalling pathway to translational control. Cell 1996; 86: 517-20.
21. Sahin F, Kannangai R, Adegbola O, Wang J, Su G, Torbenson M. mTOR and P70 S6 kinase expression in primary liver neoplasms. Clin Cancer Res 2004; 10: 8421-5.
22. Zhang H, Stallock JP, Ng JC, Reinhard C, Neufeld TP. Regulation of cellular growth by the Drosophila target of rapamycin dTOR. Genes Dev 2000; 14: 2712-24.
23. Wilson KF, Wu WJ, Cerione RA. Cdc42 stimulates RNA splicing via the S6 kinase and a novel S6 kinase target, the nuclear Cap-binding complex. J Biol Chem 2000; 275: 37307-10.
24. Wu A, Tu X, Prisco M, Baserga R. Regulation of upstream binding factor 1 activity by insulin-like growth factor I receptor signaling. J Biol Chem 2005; 280: 2863-72.
25. Lim MA, Kikani CK, Wick MJ, Dong LQ. Nuclear translocation of 3′-phosphoinositide-dependent protein kinase 1 (PDK-1): a potential regulatory mechanism for PDK-1 function. Proc Natl Acad Sci USA 2003; 100: 14006-11.
26. Pardo OE, Arcaro A, Salerno G, Tetley TD, Valovka T, Gout I, Seckl MJ. Novel cross talk between MEK and S6K2 in FGE-2 induced proliferation of SCLC cells. Oncogene 2001; 20: 7658-67.